KINTOR PHARMA-B Shares Surge Nearly 14% in Afternoon Trading on Strong Annual Revenue Growth

Stock News04-10

KINTOR PHARMA-B (09939) saw its shares rise nearly 14% in afternoon trading. At the time of writing, the stock was up 10.45%, trading at HK$2.96 with a turnover of HK$14.1222 million. The movement follows the company's release of its annual results, which showed revenue of approximately RMB 32.7 million, representing a year-on-year increase of 554%. The revenue growth was primarily driven by global sales of the high-end cosmetics brand KOSHINÉ, facilitated by live-streaming e-commerce. The main active ingredient in KOSHINÉ products is KX826, which is one of the company's core products. The group continues to explore various methods to further advance the global commercialization of its cosmetic products. The company plans to utilize the cash flow generated from its cosmetics sales business to fund the development and commercialization of its core products, KX-826 and GT20029, as well as other pipeline products. Simultaneously, the company remains committed to adhering to the established principles of its listed business.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment